Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 421,712 | 32,528 | 21,351 | 18,730 | 18,276 |
| Cost of Goods | 89,807 | 14,107 | 10,697 | 8,551 | 6,722 |
| Gross Profit | 331,905 | 18,421 | 10,654 | 10,179 | 11,554 |
| Operating Expenses | 42,554 | 18,956 | 16,421 | 14,212 | 11,358 |
| Operating Income | 290,158 | -428 | -5,070 | -3,482 | 918 |
| Other Income | -3,316 | 60 | -501 | -43 | -5,386 |
| Pre-tax Income | 286,842 | -368 | -5,571 | -3,525 | -4,468 |
| Income Tax | 72,532 | 43 | 36 | -1,015 | 920 |
| Net Income Continuous | 214,310 | -411 | -5,607 | -2,510 | -5,388 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 41 |
| Net Income | $214,310 | $-411 | $-5,607 | $-2,510 | $-5,347 |
| EPS Basic Total Ops | 9.44 | -0.02 | -0.31 | -0.14 | -1.00 |
| EPS Basic Continuous Ops | 9.44 | -0.02 | -0.31 | -0.14 | -0.39 |
| EPS Diluted Total Ops | 8.91 | -0.02 | -0.31 | -0.14 | -1.00 |
| EPS Diluted Continuous Ops | 8.91 | -0.02 | -0.31 | -0.14 | -0.39 |
| EPS Diluted Before Non-Recurring Items | 8.85 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $293,977 | $1,785 | $-2,610 | $-1,384 | $2,151 |